38 results
8-K
EX-99.1
EYPT
EyePoint Pharmaceuticals Inc
1 Nov 23
EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
trial in wet AMD at the OIS Retina Innovation Summit in July. In addition to positive safety data, an analysis of the reported patient demographics
8-K
EX-99.1
kmb9 hfnzp3
2 Aug 23
EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments
7:05am
8-K
pf18kfgdhikmw 020
27 Jul 23
Other Events
4:06pm
8-K
EX-99.1
fujw215g260oos7
27 Jul 23
Other Events
4:06pm
8-K
EX-99.1
o4pkmoxwe2nub3pu9br
13 May 22
Other Events
2:17pm
8-K/A
EX-99.1
yml7the507jv2dc
12 Jan 22
Other Events
4:02pm
8-K
EX-99.2
p5e9ym5hrhlp7
10 Jan 22
EyePoint Pharmaceuticals Announces 2022 Clinical Plans and Highlights Recent Corporate and Clinical Achievements
8:06am
8-K
EX-99.2
2mraqfihddnti7
15 Nov 21
Other Events
6:50am
8-K
EX-99.1
kan17j f66mb
17 Aug 21
Other Events
4:25pm
8-K
EX-99.1
tic56 pfe
2 Jun 21
Other Events
7:00am